Phase I and pharmacological study of oral topotecan and the BCRP and P-gp inhibitor elacridar

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 2003-2003 ◽  
Author(s):  
J. H. Schellens ◽  
I. E. Kuppens ◽  
R. C. Jewell ◽  
S. A. Radema ◽  
E. O. Witteveen ◽  
...  
Keyword(s):  
Phase I ◽  
Pharmacological Study ◽  
Oral Topotecan

Phase I and pharmacological study of oral topotecan and the BCRP and P-gp inhibitor elacridar

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 2003-2003
Author(s):  
J. H. Schellens ◽  
I. E. Kuppens ◽  
R. C. Jewell ◽  
S. A. Radema ◽  
E. O. Witteveen ◽  
...  
Keyword(s):  
Phase I ◽  
Pharmacological Study ◽  
Oral Topotecan

Five days of oral topotecan (hycamtin®), a phase I and pharmacological study in adult patients with solid tumours

1998 ◽  
Vol 34 (7) ◽  
pp. 1030-1035 ◽  
Author(s):  
C.J.H Gerrits ◽  
H Burris ◽  
J.H.M Schellens ◽  
A.S.T Planting ◽  
M.E.L van den Burg ◽  
...  
Keyword(s):  
Phase I ◽  
Pharmacological Study ◽  
Solid Tumours ◽  
Adult Patients ◽  
Oral Topotecan

scholarly journals Phase I and pharmacological study of increased dose oral topotecan in combination with intravenous cisplatin

2000 ◽  
Vol 11 (9) ◽  
pp. 1205-1208 ◽  
Author(s):  
A.J. Gelderblom ◽  
W.J. Loos ◽  
M.J.A. de Jonge ◽  
A. Sparreboom ◽  
A.S.T. Planting ◽  
...  
Keyword(s):  
Phase I ◽  
Pharmacological Study ◽  
Dose Oral ◽  
Oral Topotecan

scholarly journals Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumours

2015 ◽  
Vol 113 (5) ◽  
pp. 706-715 ◽  
Author(s):  
B Milojkovic Kerklaan ◽  
M P J Lolkema ◽  
L A Devriese ◽  
E E Voest ◽  
A Nol-Boekel ◽  
...  
Keyword(s):  
Phase I ◽  
Pharmacological Study ◽  
Solid Tumours ◽  
Oral Topotecan

Myelotoxicity of oral topotecan in relation to treatment duration and dosage: a phase I study

2010 ◽  
Vol 21 (2) ◽  
pp. 202-205 ◽  
Author(s):  
George P. Stathopoulos ◽  
Alexandros Ardavanis ◽  
Pavlos Papakotoulas ◽  
Dimitrios Pectasides ◽  
George Papadopoulos ◽  
...  
Keyword(s):  
Phase I ◽  
Treatment Duration ◽  
Phase I Study ◽  
Oral Topotecan

scholarly journals A Phase I clinical and pharmacological study of cis-diamminedichloro(2-methylpyridine) platinum II (AMD473)

2003 ◽  
Vol 88 (7) ◽  
pp. 1128-1134 ◽  
Author(s):  
P Beale ◽  
I Judson ◽  
A O'Donnell ◽  
J Trigo ◽  
C Rees ◽  
...  
Keyword(s):  
Phase I ◽  
Pharmacological Study

A phase I clinical trial of weekly oral topotecan for relapsed small cell lung cancer

2013 ◽  
Vol 72 (1) ◽  
pp. 45-51 ◽  
Author(s):  
S. Agelaki ◽  
E. Kontopodis ◽  
A. Kotsakis ◽  
V. Chandrinos ◽  
I. Bompolaki ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Trial ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase I Clinical Trial ◽  
Small Cell Lung ◽  
Oral Topotecan

Feasibility, Phase I, and Pharmacological Study of Aerosolized Liposomal 9-Nitro-20(S)-Camptothecin in Patients with Advanced Malignancies in the Lungs

2006 ◽  
Vol 922 (1) ◽  
pp. 352-354 ◽  
Author(s):  
C. F. VERSCHRAEGEN ◽  
B. E. GILBERT ◽  
A. J. HUARINGA ◽  
R. NEWMAN ◽  
N. HARRIS ◽  
...  
Keyword(s):  
Phase I ◽  
Pharmacological Study ◽  
Advanced Malignancies

Phase I trial of oral topotecan with intravenous carboplatin in patients with advanced cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 3184-3184
Author(s):  
J. R. Ackler ◽  
A. Desai ◽  
J. C. Leighton ◽  
W. J. Tester
Keyword(s):  
Phase I ◽  
Advanced Cancer ◽  
Phase I Trial ◽  
Oral Topotecan

Phase I trial of oral topotecan (OT) and radiotherapy (XRT) in rectal cancer (RCA)

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 3743-3743
Author(s):  
T. Yeatman ◽  
C. M. Rocha Lima ◽  
J. Barthel ◽  
D. Calvin ◽  
C. Garret ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Phase I ◽  
Phase I Trial ◽  
Oral Topotecan
Sign in / Sign up

Export Citation Format

Share Document